[1]
S. A. Elmiladi, B. O. Abdalla, and N. A. . FAdala, “SGLT2 inhibitor: metabolic effect on Libyan patients with T2DM at National Diabetes Center in Tripoli”, LJMR, vol. 14, no. 1, pp. 25–37, Jun. 2020, doi: 10.54361/ljmr.v14i1.03.